The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Abbott (NYSE: ABT) today released new data highlighting the emotional challenges faced by people living with type 2 diabetes, ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. Tidepool ...

Many of us with loved ones living with diabetes want to see them thrive. We often think of ways we can ease some of their ...

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

We are excited to partner with Abbott to empower healthcare providers and people living with diabetes to see data from their FreeStyle Libre devices on Tidepool and Tidepool+,” said Brandon ...